Optimizing Venlafaxine Therapy in Pregnancy: A Maternal–Fetal PBPK Modeling Approach
Drug Design, Development and Therapy · 2025
DOI: 10.2147/dddt.s553888 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Seo-Yeon Choi und 2 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Research Institute of Pharmaceutical Sciences, Kyungpook National University, Daegu, Republic of Korea. Hauptthemen laut MEDLINE: Venlafaxine Hydrochloride, Models, Biological, Maternal-Fetal Exchange. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Research Institute of Pharmaceutical Sciences, Kyungpook National University, Daegu, Republic of Korea.
- Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA, USA.
- Infectious Disease Healthcare, Kyungpook National University, Daegu, Republic of Korea.
ORCID-Profile: Kwang-Hee Shin
Zitieren
APA
Choi, S. Y., Yang, E., & Shin, K. H. (2025). Optimizing Venlafaxine Therapy in Pregnancy: A Maternal–Fetal PBPK Modeling Approach. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s553888
Vancouver
Choi SY, Yang E, Shin KH. Optimizing Venlafaxine Therapy in Pregnancy: A Maternal–Fetal PBPK Modeling Approach. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s553888
BibTeX
@article{Choi2025,
author = {Choi, Seo-Yeon and Yang, Eunsol and Shin, Kwang-Hee},
title = {Optimizing Venlafaxine Therapy in Pregnancy: A Maternal–Fetal PBPK Modeling Approach},
journal = {Drug Design, Development and Therapy},
year = {2025},
doi = {10.2147/dddt.s553888}
}
EUVIMED